Literature DB >> 11491167

Lung cancer in patients with idiopathic pulmonary fibrosis.

J Park1, D S Kim, T S Shim, C M Lim, Y Koh, S D Lee, W S Kim, W D Kim, J S Lee, K S Song.   

Abstract

Idiopathic pulmonary fibrosis (IPF) was reported to be associated with increased risk of lung cancer as a result of the occurrence of atypical or dysplastic epithelial changes in fibrosis which progressed to invasive malignancy. In that situation, the cancer will develop in the area of major fibrosis. To investigate the direct relationship between fibrosis and cancer development, the real concordance rate of the two lesions in the chest computed tomography (CT) was analysed and compared to the histological types of lung cancer. The subjects included 63 patients with combined lung cancer and IPF (IPF-CA), 218 patients with lone IPF, and 2,660 patients with primary lung cancer. All patients were diagnosed at Asan Medical Center during the same period. The age, percentage of smokers, and the male sex were significantly higher in IPF-CA compared with lone IPF. The odds ratio of smoking was 2.71 compared to nonsmoking IPF controls. In IPF-CA, 56% of the cancer was located in the periphery of the lung and 52% in the upper lobe. The majority of the cancers (64%) were found in the nonfibrotic area at chest CT. The most frequent cell type was squamous cell carcinoma (35%), and there was no significant difference in the cancer cell type between IPF-CA and total lung cancer population. These findings suggest that in combined lung cancer and idiopathic pulmonary fibrosis patients, the features of the lung cancer are similar to the total lung cancer population.

Entities:  

Mesh:

Year:  2001        PMID: 11491167     DOI: 10.1183/09031936.01.99055301

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  69 in total

1.  Is interstitial pneumonia in patients with collagen diseases a contraindication to lung cancer surgery?

Authors:  Jun Nakajima; Shinichi Takamoto; Tomohiro Murakawa; Takeshi Fukami; Atsushi Sano
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

Review 2.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.

Authors:  Shinsaku Yamaguchi; Takayuki Ohguri; Yuichi Matsuki; Katsuya Yahara; Hodaka Oki; Hajime Imada; Hiroyuki Narisada; Yukunori Korogi
Journal:  Int J Clin Oncol       Date:  2014-03-11       Impact factor: 3.402

4.  Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.

Authors:  Y Hasegawa; M Takahashi; S Ariki; D Asakawa; M Tajiri; Y Wada; Y Yamaguchi; C Nishitani; R Takamiya; A Saito; Y Uehara; J Hashimoto; Y Kurimura; H Takahashi; Y Kuroki
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

Review 5.  Cytoglobin in tumor hypoxia: novel insights into cancer suppression.

Authors:  Sankalpa Chakraborty; Rince John; Alo Nag
Journal:  Tumour Biol       Date:  2014-05-10

Review 6.  High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis.

Authors:  N Sverzellati; M De Filippo; T Bartalena; S Piciucchi; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

Review 7.  Triggering the landslide: The tumor-promotional effects of myofibroblasts.

Authors:  Christine Mehner; Derek C Radisky
Journal:  Exp Cell Res       Date:  2013-03-22       Impact factor: 3.905

Review 8.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

9.  Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.

Authors:  Naohiro Watanabe; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Masashi Kondo; Yoshinori Hasegawa
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

Review 10.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.